I thought this was interesting. Its is research on how long 510ks take to get approved by FDA

http://www.emergogroup.com/research/fda-510k-review-times-research

That was from May 21,2013 man! not this year

Because no CEO would go on Facebook to clear any situation up.

NVM that was it. my mistake, you just didnt post the table that is below the words.


Some of our shareholders have asked about how our products differ from the widely advertised product, IcyHot® Smart Relief™ Pain Relief TENS manufactured by the large European pharmaceutical Sanofi (33 billion annual sales). This is very good news and illustrates a positive sign of the change in the industry approach to pain control. A pharma company the size of Sanofi has realized both the market need and potential market size for drug-free pain relief. However, their Icy Hot Smart relief products have some significant shortcomings compared to BioElectronics products.

The ActiPatch® and IcyHot® Smart Relief™ TENS technology provide different clinical applications. ActiPatch® repairs and regenerates damaged cells by reducing pain and inflammation and accelerating blood flow. Whereas, TENS is only blocking pain signals and has no healing effect.


ActiPatch® Technology


Smart Relief™ TENS Technology





why_smart_choice_page_img01

Pain Relief


Advanced Long-Lasting


Short Term Intermittent

Application


Device can be adhered with adhesive or inserted in comfortable back or knee wrap


Apply electrodes on skin

Acceleration of Healing


Clinically proven to accelerate healing


None

Safety


ActiPatch® is 100% safe to use and has no side effects


TENS: may cause skin irritation with long term use

Duration of Long-Lasting Treatment


BIEL:24/7 continuous treatment for 720 hours of controlled use


Typical treatment period 20-30 min period

Price


$29.95

TENS:
$34.95 for unit and approximately $30/month for replacements

Mechanism of Action


ActiPatch® repairs and regenerates damaged cells by reducing pain and inflammation and accelerating blood flow


TENS temporarily blocks pain signals by confusing nerve signals

We effectively compete with store brand TENS units in the UK. We’ve received a number of testimonials from UK customers saying that they found ActiPatch Therapy more effective and easier to use than TENS units.

We expect continued growth in sales as our satisfied customers continue to spread the word – supported by strategic advertising buys and public relations activities.

There is actually another PR i found yesterday that list a ton of details on why they are different. Ill find it and post it. give me 15

Glad to be here, thanks seven

Ed cant blow that date. Only the Auditors can.

With more than 7 billion shares and not a whole lot of sales (million +) I am not sure I agree with the .05-.10, you may be right but it just seems tough.

STOCK! WE GET IT. BUT, what if they get approval, sales are good, they buy back shares! instead of R/S. solves problems

Or they can buy back shares over a period of time and not do a R/S. This would alleviate any concern. If they get approval that is. I am guessing you disagree though?

I actually thought today would be a red day, even after yesterday news. reason being is because i thought a lot of people would short, and then i felt tomorrow would be green. However, with the mistake. I dunno anymore

I am surprised. People must have not understood the significance of last nights PR. Other wise this would be in the low 3's right now.

20 business days, so i believe that is monday

What is the benefit of them holding it down? (serious question)

What do you guys think the increase will be tomorrow? 2 cents?

This made it to the WSJ. WOW!

http://online.wsj.com/article/PR-CO-20140716-910648.html

Folsom, CA / ACCESSWIRE / July 16, 2014 / MyECheck, Inc. (OTC PKINK: MYEC), an electronic payment solutions provider and the leader in fully electronic check technology today announced that has entered into a new agreement with Simplifile, LC, a current MyECheck customer, to dramatically increase the transaction volume that MyECheck processes for Simplifile.

MyECheck's fully electronic check service allows Simplifile to collect payments from customer accounts that cannot be debited by ACH, such as certain escrow accounts and government account. As a result of using MyECheck's technology side by side with ACH, Simplifile has decided to convert their business to MyECheck's fully electronic check service, replacing ACH.

Under the new agreement, Simplifile's fee structure has been brought in-line with current MyECheck pricing, which will help Simplifile support a large scale transition to MyECheck's services.

Ed Starrs, MyECheck CEO commented, "We're proud to have gained the trust of a long term customer, that we can help them grow, and that they recognize the benefits and value of MyECheck services over ACH."

About Simplifile: Simplifile is e-recording made simple. Since 2002, Simplifile has spearheaded the development of the e-recording industry, growing the largest e-recording network in the nation...with the happiest customers.

Simplifile's team, products, and e-recording services are second to none. A straightforward, secure delivery liaison between counties and document submitters, Simplifileprovides an easy-to-use online service that speeds up the recording process, saves time and money, and makes people smile along the way.

About MyECheck: MyECheck Inc. is a leading electronic payment technology developer and payment services provider. MyECheck operates under license to US Patent 7,389,913, "Method and Apparatus for Online Check Processing" granted June 2008. The new patented payment method is the fastest, most secure and most cost effective method of processing payments in the US, and it works with the most people, businesses and entities. MyECheck provides comprehensive payment systems for all payment applications including mobile payments and the industry's most advanced security and fraud control technologies. MyECheck customers include corporations, retailers, governments, payment processors and financial institutions.

Please visit: www.myecheck.com

Forward-looking statements in this release are made pursuant to "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of mentioned products, increased levels of competition, new products and technological changes, dependence upon third-party suppliers, intellectual property rights, and other risks detailed from time to time in reports filed with the SEC.

As in it was a "What-if" Scenario

Where did you hear of a 50M licensing deal?

Thank you Seven-UP

Alright, I will hold because if I sell, Im only getting 400 bucks, I invest 3K. Its not a life threatening loss. But it is frustrating just because they have a good product according to users but it seems Biel just doesn't care. How do you not have clinical studies completed when you know you need to go to FDA? I am not a business owner so I do not know what it all entails. So maybe I am wrong in thinking they should have been ready. Ill give them to December. It seems as though a lot of people have actually sold. For the past couple months, its been mainly red days.

I really just dont think this is worth holding anymore, might just cut my losses and bounce. I cant decide...someone offer some information for both sides

Wednesday Fight

Please do not hold your breath! You will surely pass out by the time this puppy makes a move. I am holding till I hear whether that well was delayed again or not. This time they can not blame weather. So it will be interesting to hear. If they announce something crazy, like OIL!!!!!!! then you can take this post, print it, burn it, send it to me in the mail, with a letter that says, "Your an Idiot"...... but if they announce, hey we are still drilling due to other issues, then you can buy me a gift card to Morton's steak house, with the 50 dollars that will be left for everyone.

Reverse Stock splits and stock splits do not effect preferred shares. If you have 20 c/s issued and 5 Preferred shares. afterstock split of 2:1 you would have 40-5 respectively

Luigi....your and idiot. Plain and Simple.

Whitefish, did you just get done studying for FAR hahahaha, love it man, your nailing it.

And your also capitalizing that expense with that sucessful litigation so two benies right there

good point, I am an auditor. I would agree.

Anyone else surprised this is still trading in the mid 2's esp with the F/S coming up and the recent news about office space? seems weird to me.

Whitefish, "should" is much different than "required" FASBs are more of a grey area sometimes and when they use the word "should", this usually is followed up by a revaluation every year testing for impairment

Does anyone know when this amazing, well performing, best stock in a portfolio, turns back to FNRC?

Call the close today. Winner gets to eat one hell of a chicken dinner

I never thought today would be a red day. Not after yesterdays news. pisses me off really, not because its going down but becuase people are stupid and selling. Dont they wanna make money. I KNOW WHAT I HOLD! MYEC 4 LIFE

No one ripped us off. This company is not doing well. MM's have nothing to do with it. I doubt they are even watching the stock.

hahahaha No, But i own about 250K and I still wouldnt want one

Does anyone think there would ever be a R/S. I am not saying THERE IS ONE. I am asking, in a hypothetical situation, would there be one?

Amazing surge, than back to low volume. WTF "DUDES"

hahahaha.. your right, ill just get cases of coars.

Are we really sitting at 30 cents after a 20,000 R/S? I have 200 shares worth 60 bucks. Im laughing out of pitty for this company. My god man. They better have something good to say, otherwise im taking out my 60 bucks, giving 10 to etrade, and buying as many 6 packs as I can with 50 bucks.

Is there a time frame for FDA approval or is it "soon" meaning it could be a year